Organism 103712 -

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Organism Details

Property	Value
Family
Genus
Species
Species authority
Subspecies
Subspecies authority
Comment
Citation	MOHAMMAD,RM: VARTERASIAN,ML: ALMATCHY,VP: HANNOUDI,GN: PETTIT,GR: AL-KATIB,A:. (1998). SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTE LEUKEMIA XENOGRAFTS WITH COMBINATION BIOLOGICAL AGENTS AURISTATIN PE AND BRYOSTATIN 1.. 4(5)

Experiments

6 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
375300	PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Empty organism	BRYOSTATIN 1
375301	PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Empty organism	BRYOSTATIN 1
375302	PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Empty organism	BRYOSTATIN 1
375303	PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Empty organism	BRYOSTATIN 1
375304	PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS	APOPTOSIS INDUCTION	Empty organism	BRYOSTATIN 1
375305	PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIMITOTIC ACTIVITY	Empty organism	BRYOSTATIN 1

Organism 103712 -

Organism Details

Experiments

Filters

Worktypes (4)

Pharmacology (4)

Show SPARQL Queries (1)

Query 1